Implicating ferroptosis inducers that stimulate STAT1 activation may overcome tumor resistance to immunotherapy, providing a wide range of potential for the clinical implementation of ferroptosis inducers in combination with immune checkpoint inhibitors (ICIs) (9). Here, STAT1 is linked to neoplasm.